Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Completed × Observational × Keratosis × Clear all

Status

Sponsor Class

Study Type

Interventional 6 Observational 1

Sponsor

Cancer Type

Conditions

Breast Neoplasms 1156 Neoplasms 970 Colorectal Neoplasms 520 Lung Neoplasms 455 Prostatic Neoplasms 454 Carcinoma, Non-Small-Cell Lung 368 Carcinoma, Hepatocellular 240 Stomach Neoplasms 231 Pancreatic Neoplasms 220 Colonic Neoplasms 214 Ovarian Neoplasms 191 Rectal Neoplasms 184 Melanoma 183 Head and Neck Neoplasms 182 Multiple Myeloma 173 Uterine Cervical Neoplasms 161 Precursor Cell Lymphoblastic Leukemia-Lymphoma 155 Leukemia 155 Lymphoma 153 Neoplasm Metastasis 147 Esophageal Neoplasms 147 Carcinoma, Renal Cell 145 Brain Neoplasms 138 Leukemia, Myeloid, Acute 129 Urinary Bladder Neoplasms 116 Polycystic Ovary Syndrome 104 Recurrence 100 Hematologic Neoplasms 97 Endometrial Neoplasms 92 Liver Neoplasms 89

Interventions

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT00114023 2007-02-19

1-Year Follow up to the 1473-IMIQ Study

Graceway Pharmaceuticals, LLC

Keratosis, Keratosis, Actinic

Data powered by HemOnc (CC BY 4.0) Colophon ⚡